A Study of Toripalimab or Placebo Plus Chemotherapy as Treatment in Early Stage NSCLC

Condition:   Stage IIIA Non-small Cell Lung Cancer Interventions:   Drug: Toripalimab + platinum-based doublet chemotherapy;   Drug: Placebo + platinum-based doublet chemotherapy Sponsor:   Shanghai Junshi Bioscience Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials